New research describes the role of RANKL-expressing Th17 cells in inflammatory bone destruction. (posted June 3, 2013)
TNF-α Impairs Regulatory T Cells in Patients with Rheumatoid Arthritis
When researchers treated patients with RA with TNF-α–specific antibody, they were able to restore Treg cell function. (posted June 3, 2013)
Rheumatologists on the Move
Awards, appointments, and announcements in the world of rheumatology
Coding Corner Answer: June Coding Challenge
What you need to know to prepare for, or appeal, a Medicare audit
Coding Corner Question: June
Test your knowledge of Medicare audits
Practice Page: The ACR’s Insurance Subcommittee Facilitates Better Communication With Health Insurers for Rheumatology Practices
Committee is working to develop policy and programs to help ACR members deal with the administrative requirements of health insurance plans
Tofacitinib and Other Kinase Inhibitors Offer New Approach to Treating Rheumatoid Arthritis
Small molecule kinase inhibitors, such as JAK inhibitors, provide a novel route for rheumatic disease treatment—and may promote our understanding of the immune system’s complexities
What Rheumatologists Need to Know about Identifying Amyloidosis
Although amyloidosis is not a rheumatic disease, rheumatologists may be the first to diagnose this life-threatening condition
Advances in Genomics, Bioinformatics Draw New Insights From the Human Genome
Widely held belief that large segments of the human genome consist of ‘junk DNA’ is incorrect, say scientists
A Rheumatologist’s Tips for Tweeting and Blogging
Paul Sufka, MD, networks almost daily with physicians worldwide about new medical approaches, research, or treatments
- « Previous Page
- 1
- …
- 652
- 653
- 654
- 655
- 656
- …
- 816
- Next Page »